000			02024nam a2200421 i 4500
999			_c277756 _d277756
001			on1078149854
003			OCoLC
005			20190115095839.0
007			he bmb024bbca
008			181206s2018 dcu bb f000 0 eng c
040			_aPUCPR _beng _erda _cGPO _dGPO _dMvI
042			_apcc
043			_an-us---
074			_a1016-B (MF)
086	0		_aY 4.G 74/7:115-54
088			_aSerial no. 115-54 (United States. Congress. House. Committee on Oversight and Government Reform)
099			_aY 4.G 74/7:115-54
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Oversight and Government Reform,
245	1	0	_aFederally funded cancer research : _bcoordination and innovation : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 29, 2017.
264		1	_aWashington : _bU.S. Government Publishing Office, _c2018.
300			_aiii, 62 pages ; _c24 cm
336			_btxt
337			_bh _2rdamedia
338			_bhe _2rdacarrier
500			_a"Serial no. 115-54."
500			_aShipping list no.: 2018-0186-M.
500			_aCRDP Program record.
504			_aIncludes bibliographical references.
533			_aMicrofiche. _b[Washington, D.C.] : _cU.S. Government Printing Office, _d[2018] _e1 microfiche : negative.
776	0	8	_iPrint version: _aUnited States. Congress. House. Committee on Oversight and Government Reform. _tFederally funded cancer research _w(OCoLC)1038068595
776	0	8	_iOnline version: _aUnited States. Congress. House. Committee on Oversight and Government Reform. _tFederally funded cancer research _w(OCoLC)1037274890
050		4	_aKF27 _b.O94 2017l
610	2	0	_aNational Institutes of Health (U.S.) _xAppropriations and expenditures.
610	2	0	_aNational Cancer Institute (U.S.) _xAppropriations and expenditures.
650		0	_aCancer _xResearch _zUnited States _xFinance.
655		7	_aLegislative hearings. _2lcgft
942			_2sudocs _c8